Alterity Therapeutics (ATHE) EBT (2016 - 2019)

Alterity Therapeutics has reported EBT for 4 years, with the latest figure at -$3.9 million in Q4 2019.

• On a quarterly basis, EBT fell 0.58% year-over-year to -$3.9 million in Q4 2019; TTM through Dec 2019 was -$13.2 million, a 32.09% increase from a year earlier, with the FY2026 full-year figure at -$16519.0 billion, down 113.53% from the prior year.
• EBT was -$3.9 million for Q4 2019 at Alterity Therapeutics, down from -$3.8 million in the prior quarter.
• The five-year high for EBT was -$2.7 million in Q4 2016, with the low at -$3.9 million in Q4 2019.
• Average EBT over 4 years is -$3.3 million, with a median of -$3.3 million recorded in 2017.
• The sharpest annual moves came in 2018 and 2019: EBT slumped 37.71% in 2018, then retreated 0.58% in 2019.
• Over 4 years, EBT stood at -$2.7 million in 2016, then declined by 1.55% to -$2.8 million in 2017, then tumbled by 37.71% to -$3.8 million in 2018, then declined by 0.58% to -$3.9 million in 2019.
• The last three EBT figures came in at -$3.9 million (Q4 2019), -$3.8 million (Q4 2018), and -$2.8 million (Q4 2017), per Business Quant data.